Package 60505-0261-1

{"route": ["ORAL"], "spl_id": "4bc1d8b0-abd1-a719-49bf-3278164bc3ac", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["N1SN99T69T", "0J48LPH2TH"], "rxcui": ["898362", "898367", "898372", "898378"], "spl_set_id": ["e7222f81-3e6b-dfe1-379a-83ca350f91a9"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (60505-0261-1)", "package_ndc": "60505-0261-1", "marketing_end_date": "20260228", "marketing_start_date": "20140821"}], "brand_name": "benazepril hydrochloride and hydrochlorothiazide", "product_id": "60505-0261_4bc1d8b0-abd1-a719-49bf-3278164bc3ac", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "60505-0261", "generic_name": "benazepril hydrochloride and hydrochlorothiazide", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "benazepril hydrochloride and hydrochlorothiazide", "active_ingredients": [{"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "6.25 mg/1"}], "application_number": "ANDA078794", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20140821"}